News
Important Only
New York Times Says New York Times Company And Amazon Announce Licensing Agreement
May 29 (Reuters) - NEW YORK TIMES- NEW YORK TIMES COMPANY AND AMAZON ANNOUNCE LICENSING AGREEMENTNEW YORK TIMES- UNDER THE DEAL AMAZON IS LICENSING EDITORIAL CONTENT FROM THE NEW YORK TIMES, NYT COOKING, AND THE ATHLETIC FOR AI-RELATED USESSource: https://tinyurl.com/2n7rywe2Reuters
Thu, May 29
EXCLUSIVE-Grammarly secures $1 billion from General Catalyst to build AI productivity platform
Grammarly plans strategic acquisitions and AI tool expansionGeneral Catalyst's investment return linked to Grammarly's revenue growthGrammarly aims for public offering, no immediate plansBy Krystal HuMay 29 - Grammarly has raised $1 billion in non-dilutive financing from General Catalyst to ...Reuters
Thu, May 29
Bionique Testing Laboratories and Cellipont Bioservices Partner to Accelerate Adoption of Rapid Mycoplasma Testing in Cell and Gene Therapy Manufacturing
May 29 (Reuters) - BIONIQUE TESTING LABORATORIES: CO, CELLIPONT BIOSERVICES PARTNER TO ACCELERATE ADOPTION OF RAPID MYCOPLASMA TESTING IN & GENE THERAPY MANUFACTURINGReuters
Thu, May 29
Karman Space & Defense Acquires Industrial Solid Propulsion
May 29 (Reuters) - Karman Holdings Inc KRMN.N:KARMAN SPACE & DEFENSE ACQUIRES INDUSTRIAL SOLID PROPULSION (“ISP”), A LEADING SUPPLIER OF ENERGETIC PROPULSION TECHNOLOGIES FOR NEXT-GENERATION UAS, UAS INTERCEPT AND ROCKET-ASSISTED TAKEOFF SYSTEMSReuters
Thu, May 29
Liberty Media - LNSPV Enters 2025 Forward Contracts With Dealers To Deliver Up To 10.5 Million Shares Of Live Nation Stock
May 29 (Reuters) - Liberty Media Corp FWONA.O:LIBERTY MEDIA - LNSPV ENTERS 2025 FORWARD CONTRACTS WITH DEALERS TO DELIVER UP TO 10.5 MILLION SHARES OF LIVE NATION STOCK - SEC FILINGReuters
Thu, May 29
Estrella Immunopharma Initiates Second Cohort and Doses First Patient in STARLIGHT-1 Trial of EB103 in Advanced B-Cell Non-Hodgkin’s Lymphomas
May 29 (Reuters) - Estrella Immunopharma Inc ESLA.O:ESTRELLA IMMUNOPHARMA INITIATES SECOND COHORT AND DOSES FIRST PATIENT IN STARLIGHT-1 TRIAL OF EB103 IN ADVANCED B-CELL NON-HODGKIN’S LYMPHOMASReuters
Thu, May 29
Ccc Intelligent Solutions Selected By Premium Automaker To Help Drivers Connect With Certified Repairers And Take The First Step Toward Repair
May 29 (Reuters) - CCC Intelligent Solutions Holdings Inc CCCS.O:CCC INTELLIGENT SOLUTIONS SELECTED BY PREMIUM AUTOMAKER TO HELP DRIVERS CONNECT WITH CERTIFIED REPAIRERS AND TAKE THE FIRST STEP TOWARD REPAIRReuters
Thu, May 29
